Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Martin Wax, MD
PanOptica, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Axon Clinical
Prague, Czechia
- Fakultní Nemocnice Královské Vinohrady
Prague, Czechia
- Semmelweis University
Budapest, Hungary
- University of Debrecen
Debrecen, Hungary
- P. Stradina Clinical University Hospital
Riga, Latvia
- Barnet Hospital
Barnet, Hertfordshire, United Kingdom
- New Cross Hospital
Wolverhampton, West Midlands, United Kingdom
- Bradford Royal Infirmary
Bradford, United Kingdom
- Moorefields Eye Hospital
London, United Kingdom
- Manchester Royal Eye Hospital
Manchester, United Kingdom
- Colorado Retina Associates
Golden, Colorado, United States
- Cumberland Valley Retina Consultants
Hagerstown, Maryland, United States
- Retinal Consultants of Nevada
Henderson, Nevada, United States
- Retinal Consultants of Nevada
Las Vegas, Nevada, United States
- Retina Center of New Jersey
Bloomfield, New Jersey, United States
- Retina Center of New Jersey
Teaneck, New Jersey, United States
- Vision Research Center
Albuquerque, New Mexico, United States
- Duke University
Durham, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Apr 2018
- Primary completion
- 27 May 2019
- Completion
- 27 Jun 2019
- Last update posted
- 9 Jul 2019
- Registered enrollment
- 51
- Registry id
- NCT03479372
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.